Can-Fite BioPharma Ltd.
CANF
$0.53
-$0.04-6.81%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.46M | 6.46M | 7.89M | 7.89M | 4.73M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.17M | 1.17M | 1.02M | 1.02M | 1.10M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 77.00K | 77.00K | -- |
| Total Current Assets | 7.62M | 7.62M | 8.98M | 8.98M | 5.83M |
|
|
|||||
| Total Current Assets | 7.62M | 7.62M | 8.98M | 8.98M | 5.83M |
| Net Property, Plant & Equipment | 96.00K | 96.00K | 138.00K | 138.00K | 94.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 7.72M | 7.72M | 9.12M | 9.12M | 5.92M |
|
|
|||||
| Total Accounts Payable | 1.15M | 1.15M | 618.00K | 618.00K | 885.00K |
| Total Accrued Expenses | 506.00K | 506.00K | 976.00K | 976.00K | 430.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 57.00K | 57.00K | 53.00K | 53.00K | 36.00K |
| Total Finance Division Other Current Liabilities | 405.00K | 405.00K | 405.00K | 405.00K | 636.00K |
| Total Other Current Liabilities | 405.00K | 405.00K | 405.00K | 405.00K | 636.00K |
| Total Current Liabilities | 2.12M | 2.12M | 2.05M | 2.05M | 1.99M |
|
|
|||||
| Total Current Liabilities | 2.12M | 2.12M | 2.05M | 2.05M | 1.99M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 33.00K | 33.00K | 51.00K | 51.00K | 21.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.38M | 1.38M | 1.58M | 1.58M | 1.44M |
| Total Liabilities | 3.54M | 3.54M | 3.68M | 3.68M | 3.44M |
|
|
|||||
| Common Stock & APIC | 174.29M | 174.29M | 170.67M | 170.67M | 163.79M |
| Retained Earnings | -171.24M | -171.24M | -166.36M | -166.36M | -162.44M |
| Treasury Stock & Other | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M |
| Total Common Equity | 4.18M | 4.18M | 5.44M | 5.44M | 2.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.18M | 4.18M | 5.44M | 5.44M | 2.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.18M | 4.18M | 5.44M | 5.44M | 2.48M |
|
|
|||||